Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huahai Vitiligo Hospital, also known as the Huahai Institute of Vitiligo Research, is a specialized medical and research institution based in Binzhou, China, dedicated to the treatment of vitiligo. Founded by Cheng Aihua in 1994, the institute is globally recognized for its proprietary "Black and White Treatment" (Heibai Tongzhi) methodology, which integrates Traditional Chinese Medicine (TCM) with modern immunological science. The organization operates a large-scale clinical facility and has developed several TCM-based pharmaceutical products approved for the restoration of skin pigmentation. It serves as a national key specialized hospital in China and has expanded its reach through international collaborations and telemedicine services. The institute's research focuses on regulating the immune system and activating tyrosinase to promote melanocyte regeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huahai Institute of Vitiligo Research.